TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00201838 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04597957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00171080 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02626273 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00712881 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01869699 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00550485 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00904293 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT00904293 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03091192 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03091192 — Predictive Biomarker (PRD): PRCC mRNA
Genes: PRCC; TPRC
Study NCT01622751 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT01657097 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT02855671 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02198092 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02354781 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT02354781 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02262806 — Surrogate Endpoint (SUR): Serum hemoglobin A1C
Study NCT02262806 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT01608867 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02220621 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03606980 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT01961661 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00524849 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00524849 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00356616 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04073602 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02407470 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01068418 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04575415 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04575415 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04286425 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT03663881 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04607928 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00636467 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT04136184 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06706700 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT00628368 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04304781 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04304781 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04304781 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04333914 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study NCT00566774 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02659514 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02659514 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00270153 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00270153 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00270153 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00811343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00087763 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01292694 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01395342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04697043 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04697043 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06046924 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01364636 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03393715 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03393715 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04642040 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04623879 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00924287 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00327080 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00327080 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02206984 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04197882 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01163669 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04832711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00621309 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT00621309 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00302562 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT01329003 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01760239 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02481310 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT02479568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01681810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04155268 — Predictive Biomarker (PRD): REST mRNA
Genes: REST; NRSF; XBR
Study NCT00725647 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02891174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04196803 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT00083057 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00083057 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00111670 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05531695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05531695 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT05531695 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study NCT05531695 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00914992 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03901339 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03901339 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03901339 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01369836 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02393924 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05590780 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02153671 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT02994420 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03517189 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03517189 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT03517189 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03704350 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT03070769 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01698879 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01698879 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00950066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00696059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02077348 — Predictive Biomarker (PRD): PNPLA2 mRNA
Genes: PNPLA2; ATGL; FP17548
Study NCT04193046 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01233869 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT03512106 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01935492 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01240369 — Predictive Biomarker (PRD): VEGFC mRNA
Genes: VEGFC
Study NCT04235023 — Predictive Biomarker (PRD): PTPN1 mRNA
Genes: PTPN1; PTP1B
Study NCT02978729 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03076307 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT01951781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01951781 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02616640 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02163733 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02163733 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02650414 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05079074 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01930357 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02195765 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT01392469 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00757965 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT00757965 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT03748290 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01914835 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02320136 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT02695849 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02695849 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03512691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03514030 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT00497614 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00497614 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03809728 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT03809728 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00603317 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT00941746 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02959749 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02959749 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04087278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00079391 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02066831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00457873 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01990092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00217984 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00518531 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02095275 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02742467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02836236 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03639701 — Predictive Biomarker (PRD): TK2 mRNA
Genes: TK2
Study NCT03639701 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01221727 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02782702 — Predictive Biomarker (PRD): ATP2C1 mRNA
Genes: ATP2C1; KIAA1347; PMR1L; HUSSY-28
Study NCT02782702 — Predictive Biomarker (PRD): ATP2A2 mRNA
Genes: ATP2A2; ATP2B
Study NCT04374019 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03519464 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02830763 — Predictive Biomarker (PRD): PNPLA2 mRNA
Genes: PNPLA2; ATGL; FP17548
Study NCT04280536 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT03474042 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02052778 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT02052778 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT03748823 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03696420 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT05767866 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05767866 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00058695 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06211465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03403803 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT01846624 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04325672 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01489475 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT01761916 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01761916 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01577576 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04009317 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01274182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04165993 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03953157 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01516151 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01516151 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04622046 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00952822 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT01633684 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01101269 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00829972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04015076 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT02453620 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02453620 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01232764 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT04153227 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03397576 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01239199 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02753582 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04283448 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01125943 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01125943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00224939 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02656498 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01025492 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04163900 — Predictive Biomarker (PRD): NUCB1 mRNA
Genes: NUCB1; NUC
Study NCT03901573 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05359991 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05359991 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00346099 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01124760 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00286481 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00286481 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02605681 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01383161 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03099239 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01447368 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01447368 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01447368 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00474370 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04575025 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02042430 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT00325962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04305834 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04305834 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01936909 — Safety Biomarker (SAF): Interleukin 1
Study NCT02491567 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT02491567 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02491567 — Predictive Biomarker (PRD): PTPN22 mRNA
Genes: PTPN22; PTPN8
Study NCT02491567 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02491567 — Predictive Biomarker (PRD): FCRL3 mRNA
Genes: FCRL3; FCRH3; IFGP3; IRTA3; SPAP2
Study NCT04007068 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04074746 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02648516 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02792400 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02679599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01115842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01115842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03526887 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01824680 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01824680 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT04274504 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT02168868 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01227031 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01227031 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT02368379 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02634203 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT02634203 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04424173 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04408014 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00313222 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04178824 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04166006 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02900183 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04724070 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03641495 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT03366142 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT02230332 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT04143568 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04143568 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01051076 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02843763 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04358003 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01549626 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00354081 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00481897 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00442572 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00054275 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00689221 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02844621 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01648894 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04158011 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01827579 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT03535740 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK